References
- 1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-1053.
- 2. Gupta V, Khadgawat R, Saraswathy KN, Sachdeva MP, Kalla AK. Emergence of TCF7L2 as a most promising gene in predisposition of diabetes type II. Int J Hum Genet. 2008; 8(1-2): 199-215.
- 3. Das SK. Genetic epidemiology of adult onset T2Din Asian Indian population: Past, present and future. Int J Hum Genet. 2006; 6(1): 1-13.
- 4. Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Health. 2002; 122(1): 28-34.
- 5. Friedly LE, Philipson LH. Oxidative reactive species in cell injury: Mechanism in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 2005; 1066: 136-151.
- 6. Bekris LM, Shephard C, Peterson J, Hoehna B, Van Yserloo E, Rutledge F, et al. Glutathionestransferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity. 2005; 38(8): 567-575.
- 7. Amer MA, Ghattas MH, Abo-ElMatty DM, Abou-El-Ela SH. Influence of glutathione Stransferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res. 2011; 10(4): 3722-3730.
- 8. Ramprasath T, Senthil Murugan P, Prabakaran AD, Gomathi P, Rathinavel A, Selvam GS. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S transferase) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun. 2011; 407(1): 49-53.
- 9. Hori M, Oniki K, Ueda, Goto S, Mihara S, Marubayashi T, et al. Combined glutathione Stransferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese. Pharmacogenomics. 2007; 8(10): 1307-1314.
- 10. Datta SK, Kumar V, Pathak R, Tripathi AK, Ahmed RS, Kaira OP, et al. Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail. 2010; 32(10): 1189-1195.
- 11. Yang Y, Kao MT, Chang CC, Chen CM, Tsai JJ, Chang JG. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med. 2004; 14(5): 855-859.
- 12. Hinney A. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PloS ONE. 2007; 2(12): e1361.
- 13. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. Plos Genet. 2007; 3(7): 1200-1210.
- 14. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM, et al. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology. 2008; 149(5): 2062-2071.
- 15. Stratigopoulos G, Padilla SL, Leduc CA, Watson E, Hattersley AT, McCarthy MI, et al. Regulation of Fto/ Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008; 294(4):R1185-R1196.
- 16. Wahlen K, Sjolin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity- associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008; 49(3): 607-661.
- 17. Li H, Kilpeläinen TO, Liu C. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia. 2012; 55(4): 981-995.
- 18. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, Platou CG, et al. FTO, type 2 diabetes, and weight gain throughout adult life: A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes. 2011; 60(5): 1637-1644.
- 19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499-450.
- 20. Sambrook J, Frisch EF, Maniatis T, Eds. Molecular Cloning: A Laboratory Manual, 2nd ed. New York, NY: Cold Spring Harbor Press. 1989: 9.14-9.19.
- 21. Arand M, Mühlbauer R, Hengstler J, Jäger E, Fuchs J, Winkler L, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996; 236(1): 184-186.
- 22. Hao K, Niu T, Sangokoya C, Li J, Xu X. SNP kit: An efficient approach to systematic evaluation of candidate single nucleotide polymorphisms in public databases. BioTechniques. 2002; 33(4): 822-848.
- 23. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2009; 202(2): 321-329.
- 24. Wang L, Zhang Q, Li Q. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem Biophys Res Commun. 2006; 341: 310-313.
- 25. London SJ, Yuan JM, Chung FL, Gao YT. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: A prospective study of men in Shanghai, China. Lancet. 2000; 356(9231): 724-729.
- 26. Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood. 2002; 99(11): 4216-4218.
- 27. Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J. Gastroenterol. 2005; 11(3): 331-335.
- 28. Nowier SR, Kashmiry NK, Rasool HA, Morad H, Ismail S. Association of T2DMellitus and glutathione S transferase (GSTM1 and GSTT1) genetic polymorphism. Res J Med Med Sci. 2009; 4(2): 181-188.
- 29. Hossaini AM, Zamrroni IM, Kashem RA, Khan ZF. Polymorphism of glutathione S-transferases as genetic risk factors for the development of complications in T2D mellitus. J Crit Care. 2008; 23(3):444-448.
- 30. Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG, Banerjee M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med. 2010; 56(3): 176-181.
- 31. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826): 889-894.
- 32. Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, et al. Impact of nine common T2D risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12 Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008; 9: 59. doi: 10.1186/ 1471-2350-9-59.
- 33. Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni SR, Freathy RM, Prakash S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2009; 52(2): 247-252.
- 34. Pirie FJ, Motala AA, Pegoraro J, Paruk IM, Govender T, Rom L. Variants in PPARG, KCNJ11, TCF7L2, FTO, and HHEX genes in South African subjects of Zulu descent with type 2 diabetes. Afr J Diabetes Med. 2010; 18(1): 12-16.
- 35. Doney AS, Dannfald J, Kimber CH, Donnelly LA, Pearson E, Morris AD, et al. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: A Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go- DARTS) study. Circ Cardiovasc Genet. 2009; 2(3): 255-259.
- 36. Ortega-Azorín C, Sorlí JV, Asensio EM, Coltell O, Martínez-González MÁ, Salas-Salvadó J, et al. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol. 2012; 11: 137.